
The loss of patent on antidepressant Cymbalta in the US last December was largely responsible for Eli Lilly & Co’s …

Lilly’s leader is calling on governments to take the long-term view when it comes to healthcare policy. John Lechleiter who …
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine

